In December 2020, we posted about the MHRA’s draft guidance on randomised controlled trials generating real-world evidence (RWE) to support regulatory decisions. As we noted in our previous blog, although real-world data (RWD) are widely used to monitor the performance
Arnold & Porter Kaye Scholer LLP
With nearly 1,000 attorneys, Arnold & Porter provides sophisticated litigation to the life sciences and financial services industries across the globe. Their lawyers cover more than 30 practice areas including corporate finance, intellectual property, litigation, real estate, tax, and bankruptcy. With over 100 years of history, the firm offers clients forward-looking and client driven services to resolve their legal needs.
Website:
https://www.arnoldporter.com/
Latest from Arnold & Porter Kaye Scholer LLP - Page 2
EU Digital Health Policy: European Commission launches European Health Data Space
Earlier this month, the European Commission published a proposal for a Regulation for the European Health Data Space (EHDS) aimed at regulating and facilitating electronic health data access and sharing across the European Union (the Proposal). The two main objectives…
Reviewing Reversal Rates in the Second, Third, Fourth and Fifth Districts by Area of Civil Law, 1990-1999
By Kirk Jenkins
Reviewing Reversal Rates in the First District by Area of Civil Law, 1990-1999
By Kirk Jenkins
Reviewing Reversal Rates of the Third, Fourth, Fifth and Sixth Districts by Areas of Civil Law, 1990-1999
By Kirk Jenkins
Reviewing Reversal Rates of the Second District by Area of Civil Law – 1990-1999
By Kirk Jenkins
Reviewing Reversal Rates of the First District by Area of Civil Law – 1990-1999
By Kirk Jenkins